Literature DB >> 20942839

Optimization of antibacterial peptides by genetic algorithms and cheminformatics.

Christopher D Fjell1, Håvard Jenssen, Warren A Cheung, Robert E W Hancock, Artem Cherkasov.   

Abstract

Pathogens resistant to available drug therapies are a pressing global health problem. Short, cationic peptides represent a novel class of agents that have lower rates of drug resistance than derivatives of current antibiotics. Previously, we created a software system utilizing artificial neural networks that were trained on quantitative structure-activity relationship descriptors calculated for a total of 1400 synthetic peptides for which antibacterial activity was determined. Using the trained system, we correctly identified additional peptides with activity of 94% accuracy; active peptides were 47 of the top rated 50 peptides chosen from an in silico library of nearly 100,000 sequences. Here, we report a method of generating candidate peptide sequences using the heuristic evolutionary programming method of genetic algorithms (GA), which provided a large (19-fold) improvement in identification of novel antibacterial peptides. Approximately 0.50% of peptides evaluated during the GA method were classified as highly active, while only 0.026% of the nearly 100,000 sequences we previously screened were classified as highly active. A selection of these peptides was tested in vitro and activities reported here. While GA significantly improves the possibility of identifying candidate peptides, we encountered important pitfalls to this method that should be considered when using GA.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20942839     DOI: 10.1111/j.1747-0285.2010.01044.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  28 in total

Review 1.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

2.  QSAR modeling: where have you been? Where are you going to?

Authors:  Artem Cherkasov; Eugene N Muratov; Denis Fourches; Alexandre Varnek; Igor I Baskin; Mark Cronin; John Dearden; Paola Gramatica; Yvonne C Martin; Roberto Todeschini; Viviana Consonni; Victor E Kuz'min; Richard Cramer; Romualdo Benigni; Chihae Yang; James Rathman; Lothar Terfloth; Johann Gasteiger; Ann Richard; Alexander Tropsha
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

3.  Chimeric peptides as implant functionalization agents for titanium alloy implants with antimicrobial properties.

Authors:  Deniz T Yucesoy; Marketa Hnilova; Kyle Boone; Paul M Arnold; Malcolm L Snead; Candan Tamerler
Journal:  JOM (1989)       Date:  2015-04       Impact factor: 2.471

4.  Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides.

Authors:  Biljana Mojsoska; Ronald N Zuckermann; Håvard Jenssen
Journal:  Antimicrob Agents Chemother       Date:  2015-05-04       Impact factor: 5.191

5.  Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations.

Authors:  Kahini Wadhawan; Inkit Padhi; Sebastian Gehrmann; Payel Das; Tom Sercu; Flaviu Cipcigan; Vijil Chenthamarakshan; Hendrik Strobelt; Cicero Dos Santos; Pin-Yu Chen; Yi Yan Yang; Jeremy P K Tan; James Hedrick; Jason Crain; Aleksandra Mojsilovic
Journal:  Nat Biomed Eng       Date:  2021-03-11       Impact factor: 25.671

6.  Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria.

Authors:  Deepesh Nagarajan; Tushar Nagarajan; Natasha Roy; Omkar Kulkarni; Sathyabaarathi Ravichandran; Madhulika Mishra; Dipshikha Chakravortty; Nagasuma Chandra
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

7.  A New Synthetic Peptide with In vitro Antibacterial Potential Against Escherichia coli O157:H7 and Methicillin-Resistant Staphylococcus aureus (MRSA).

Authors:  Y A Prada; F Guzmán; P Rondón; P Escobar; C Ortíz; D A Sierra; R Torres; E Mejía-Ospino
Journal:  Probiotics Antimicrob Proteins       Date:  2016-09       Impact factor: 4.609

8.  Controlling the Biomimetic Implant Interface: Modulating Antimicrobial Activity by Spacer Design.

Authors:  Cate Wisdom; Sarah Kay VanOosten; Kyle W Boone; Dmytro Khvostenko; Paul M Arnold; Malcolm L Snead; Candan Tamerler
Journal:  J Mol Eng Mater       Date:  2016-08-22

9.  Structure-activity studies and therapeutic potential of host defense peptides of human thrombin.

Authors:  Gopinath Kasetty; Praveen Papareddy; Martina Kalle; Victoria Rydengård; Matthias Mörgelin; Barbara Albiger; Martin Malmsten; Artur Schmidtchen
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191

10.  Piloting the membranolytic activities of peptides with a self-organizing map.

Authors:  Yen-Chu Lin; Jan A Hiss; Petra Schneider; Peter Thelesklaf; Yi Fan Lim; Max Pillong; Fabian M Koehler; Petra S Dittrich; Cornelia Halin; Silja Wessler; Gisbert Schneider
Journal:  Chembiochem       Date:  2014-09-09       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.